Preparing for the Post-Brexit Clinical Supply Chain
Pharma Industry, Regulatory
For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now.
Related Education Resources.
All ResourcesGCSG 2024 US Conference Slides
Topic: Conference
Presentation
Members
Acting Decisively
Members
GCSG sponsored study on INVESTIGATIVE SITE Receptivity to Direct-to-Patient Shipment in Clinical Trials
Topic: Direct-to-Patient
White Paper
Members